# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-25-221756
Filing Date
2025-09-29
Accepted
2025-09-29 07:48:40
Documents
61
Period of Report
2025-09-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d942245d8k.htm iXBRL | 8-K | 36835
2 | EX-99.1 | d942245dex991.htm | EX-99.1 | 22404
3 | EX-99.2 | d942245dex992.htm | EX-99.2 | 50271
7 | GRAPHIC | g942245ex99_2s10g1.jpg | GRAPHIC | 110523
8 | GRAPHIC | g942245ex99_2s11g1.jpg | GRAPHIC | 82110
9 | GRAPHIC | g942245ex99_2s12g1.jpg | GRAPHIC | 78180
10 | GRAPHIC | g942245ex99_2s13g1.jpg | GRAPHIC | 85951
11 | GRAPHIC | g942245ex99_2s14g1.jpg | GRAPHIC | 28970
12 | GRAPHIC | g942245ex99_2s15g1.jpg | GRAPHIC | 60745
13 | GRAPHIC | g942245ex99_2s16g1.jpg | GRAPHIC | 81258
14 | GRAPHIC | g942245ex99_2s17g1.jpg | GRAPHIC | 86040
15 | GRAPHIC | g942245ex99_2s18g1.jpg | GRAPHIC | 85314
16 | GRAPHIC | g942245ex99_2s19g1.jpg | GRAPHIC | 69081
17 | GRAPHIC | g942245ex99_2s1g1.jpg | GRAPHIC | 46669
18 | GRAPHIC | g942245ex99_2s20g1.jpg | GRAPHIC | 108561
19 | GRAPHIC | g942245ex99_2s21g1.jpg | GRAPHIC | 111468
20 | GRAPHIC | g942245ex99_2s22g1.jpg | GRAPHIC | 67596
21 | GRAPHIC | g942245ex99_2s23g1.jpg | GRAPHIC | 34395
22 | GRAPHIC | g942245ex99_2s24g1.jpg | GRAPHIC | 48685
23 | GRAPHIC | g942245ex99_2s25g1.jpg | GRAPHIC | 89146
24 | GRAPHIC | g942245ex99_2s26g1.jpg | GRAPHIC | 91920
25 | GRAPHIC | g942245ex99_2s27g1.jpg | GRAPHIC | 138931
26 | GRAPHIC | g942245ex99_2s28g1.jpg | GRAPHIC | 20060
27 | GRAPHIC | g942245ex99_2s29g1.jpg | GRAPHIC | 31242
28 | GRAPHIC | g942245ex99_2s2g1.jpg | GRAPHIC | 211490
29 | GRAPHIC | g942245ex99_2s30g1.jpg | GRAPHIC | 95817
30 | GRAPHIC | g942245ex99_2s31g1.jpg | GRAPHIC | 108823
31 | GRAPHIC | g942245ex99_2s32g1.jpg | GRAPHIC | 107385
32 | GRAPHIC | g942245ex99_2s33g1.jpg | GRAPHIC | 75050
33 | GRAPHIC | g942245ex99_2s34g1.jpg | GRAPHIC | 95969
34 | GRAPHIC | g942245ex99_2s35g1.jpg | GRAPHIC | 83579
35 | GRAPHIC | g942245ex99_2s36g1.jpg | GRAPHIC | 96231
36 | GRAPHIC | g942245ex99_2s37g1.jpg | GRAPHIC | 90949
37 | GRAPHIC | g942245ex99_2s38g1.jpg | GRAPHIC | 92493
38 | GRAPHIC | g942245ex99_2s39g1.jpg | GRAPHIC | 87082
39 | GRAPHIC | g942245ex99_2s3g1.jpg | GRAPHIC | 58029
40 | GRAPHIC | g942245ex99_2s40g1.jpg | GRAPHIC | 90881
41 | GRAPHIC | g942245ex99_2s41g1.jpg | GRAPHIC | 81378
42 | GRAPHIC | g942245ex99_2s42g1.jpg | GRAPHIC | 105676
43 | GRAPHIC | g942245ex99_2s43g1.jpg | GRAPHIC | 85973
44 | GRAPHIC | g942245ex99_2s44g1.jpg | GRAPHIC | 104210
45 | GRAPHIC | g942245ex99_2s45g1.jpg | GRAPHIC | 136506
46 | GRAPHIC | g942245ex99_2s46g1.jpg | GRAPHIC | 49658
47 | GRAPHIC | g942245ex99_2s4g1.jpg | GRAPHIC | 73226
48 | GRAPHIC | g942245ex99_2s5g1.jpg | GRAPHIC | 84757
49 | GRAPHIC | g942245ex99_2s6g1.jpg | GRAPHIC | 111488
50 | GRAPHIC | g942245ex99_2s7g1.jpg | GRAPHIC | 105097
51 | GRAPHIC | g942245ex99_2s8g1.jpg | GRAPHIC | 80143
52 | GRAPHIC | g942245ex99_2s9g1.jpg | GRAPHIC | 51177
53 | GRAPHIC | g942245g0929005605053.jpg | GRAPHIC | 2617
| Complete submission text file | 0001193125-25-221756.txt |  | 5663180

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | clym-20250929.xsd | EX-101.SCH | 2839
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | clym-20250929_lab.xml | EX-101.LAB | 18735
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | clym-20250929_pre.xml | EX-101.PRE | 11699
63 | EXTRACTED XBRL INSTANCE DOCUMENT | d942245d8k_htm.xml | XML | 3766

Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 251352301
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)